Tadalafil for Severe Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease

PHASE3RecruitingINTERVENTIONAL

Enrollment

200

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

September 30, 2026

Study Completion Date

September 30, 2026

Conditions

Pulmonary HypertensionChronic Obstructive Pulmonary Disease

Interventions

DRUG

Tadalafil

Oral Tadalafil

DRUG

Placebo

Oral Placebo

Trial Locations (1)

RECRUITING

Kremlin Bicêtre, Le Kremlin-Bicêtre

All Listed Sponsors

lead

Assistance Publique - Hôpitaux de Paris

OTHER